Fig. 2From: High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohortVirological and biochemical courses of 3/18 patients responding to IFN therapy by serum HDV RNA, HBV DNA, HBsAg and ALT levelsBack to article page